Adam D Wilson1, Adrian J Bravo2, Matthew R Pearson1, Katie Witkiewitz1. 1. Department of Psychology, Center on Alcoholism, Substance Abuse and Addictions, University of New Mexico, Albuquerque, NM, USA. 2. Department of Psychology, Old Dominion University, Norfolk, VA, USA.
Abstract
AIMS: To estimate differences in post-treatment psychosocial functioning among treatment 'failures' (i.e. heavy drinkers, defined as 4+/5+ drinks for women/men) from two large multi-site clinical trials and to compare these levels of functioning to those of the purported treatment 'successes' (i.e. non-heavy drinkers). DESIGN: Separate latent profile analyses of data from two of the largest alcohol clinical trials conducted in the United States, COMBINE (Combined Pharmacotherapies and Behavioral Interventions) and Project MATCH (Matching Alcoholism Treatments to Client Heterogeneity), comparing psychosocial outcomes across derived classes of heterogeneous treatment responders. SETTING: Eleven US academic sites in COMBINE, 27 US treatment sites local to nine research sites in Project MATCH. PARTICIPANTS: A total of 962 individuals in COMBINE (69% male, 77% white, mean age: 44 years) treated January 2001 to January 2004 and 1528 individuals in Project MATCH (75% male, 80% white, mean age: 40 years) treated April 1991 to September 1994. MEASUREMENTS: In COMBINE, we analyzed health, quality of life, mental health symptoms and alcohol consequences 12 months post-baseline. In Project MATCH, we examined social functioning, mental health symptoms and alcohol consequences 15 months post-baseline. FINDINGS: Latent profile analysis of measures of functioning in both samples supported a three-profile solution for the group of treatment 'failures', characterized by high-, average- and low-functioning individuals. The high-functioning treatment 'failures' generally performed better across measures of psychosocial functioning at follow-up than participants designated treatment 'successes' by virtue of being abstainers or light drinkers. CONCLUSIONS: Current United States Food and Drug Administration guidance to use heavy drinking as indicative of treatment 'failure' fails to take into account substantial psychosocial improvements made by individuals who continue occasionally to drink heavily post-treatment.
RCT Entities:
AIMS: To estimate differences in post-treatment psychosocial functioning among treatment 'failures' (i.e. heavy drinkers, defined as 4+/5+ drinks for women/men) from two large multi-site clinical trials and to compare these levels of functioning to those of the purported treatment 'successes' (i.e. non-heavy drinkers). DESIGN: Separate latent profile analyses of data from two of the largest alcohol clinical trials conducted in the United States, COMBINE (Combined Pharmacotherapies and Behavioral Interventions) and Project MATCH (Matching Alcoholism Treatments to Client Heterogeneity), comparing psychosocial outcomes across derived classes of heterogeneous treatment responders. SETTING: Eleven US academic sites in COMBINE, 27 US treatment sites local to nine research sites in Project MATCH. PARTICIPANTS: A total of 962 individuals in COMBINE (69% male, 77% white, mean age: 44 years) treated January 2001 to January 2004 and 1528 individuals in Project MATCH (75% male, 80% white, mean age: 40 years) treated April 1991 to September 1994. MEASUREMENTS: In COMBINE, we analyzed health, quality of life, mental health symptoms and alcohol consequences 12 months post-baseline. In Project MATCH, we examined social functioning, mental health symptoms and alcohol consequences 15 months post-baseline. FINDINGS: Latent profile analysis of measures of functioning in both samples supported a three-profile solution for the group of treatment 'failures', characterized by high-, average- and low-functioning individuals. The high-functioning treatment 'failures' generally performed better across measures of psychosocial functioning at follow-up than participants designated treatment 'successes' by virtue of being abstainers or light drinkers. CONCLUSIONS: Current United States Food and Drug Administration guidance to use heavy drinking as indicative of treatment 'failure' fails to take into account substantial psychosocial improvements made by individuals who continue occasionally to drink heavily post-treatment.
Authors: Donald M Dougherty; Nora E Charles; Ashley Acheson; Samantha John; R Michael Furr; Nathalie Hill-Kapturczak Journal: Exp Clin Psychopharmacol Date: 2012-06-18 Impact factor: 3.157
Authors: Raymond F Anton; Stephanie S O'Malley; Domenic A Ciraulo; Ron A Cisler; David Couper; Dennis M Donovan; David R Gastfriend; James D Hosking; Bankole A Johnson; Joseph S LoCastro; Richard Longabaugh; Barbara J Mason; Margaret E Mattson; William R Miller; Helen M Pettinati; Carrie L Randall; Robert Swift; Roger D Weiss; Lauren D Williams; Allen Zweben Journal: JAMA Date: 2006-05-03 Impact factor: 56.272
Authors: Katie Witkiewitz; Henry R Kranzler; Kevin A Hallgren; Stephanie S O'Malley; Daniel E Falk; Raye Z Litten; Deborah S Hasin; Karl F Mann; Raymond F Anton Journal: Alcohol Clin Exp Res Date: 2018-11-05 Impact factor: 3.455
Authors: Jalie A Tucker; JeeWon Cheong; Tyler G James; Soyeon Jung; Susan D Chandler Journal: Alcohol Clin Exp Res Date: 2020-02-18 Impact factor: 3.455
Authors: Justin Knox; Melanie Wall; Katie Witkiewitz; Henry R Kranzler; Daniel E Falk; Raye Litten; Karl Mann; Stephanie S O'Malley; Jennifer Scodes; Raymond Anton; Deborah S Hasin Journal: Drug Alcohol Depend Date: 2019-05-29 Impact factor: 4.492
Authors: Katie Witkiewitz; Adam D Wilson; Matthew R Pearson; Kevin S Montes; Megan Kirouac; Corey R Roos; Kevin A Hallgren; Stephen A Maisto Journal: Addiction Date: 2018-08-24 Impact factor: 6.526
Authors: Justin Knox; Jennifer Scodes; Melanie Wall; Katie Witkiewitz; Henry R Kranzler; Daniel Falk; Raye Litten; Karl Mann; Stephanie S O'Malley; Raymond Anton; Deborah S Hasin Journal: Drug Alcohol Depend Date: 2019-02-14 Impact factor: 4.492
Authors: Charles J Holahan; Penny L Brennan; Kathleen K Schutte; Carole K Holahan; J Gregory Hixon; Rudolf H Moos Journal: J Stud Alcohol Drugs Date: 2017-05 Impact factor: 2.582
Authors: Cristina M López; Simone C Barr; Kathryn Reid-Quiñones; Michael A de Arellano Journal: J Stud Alcohol Drugs Date: 2017-05 Impact factor: 2.582